Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017Makoto Kinoshita, Shizuya Yamashita, Koutaro Yokote et al.|Journal of Atherosclerosis and Thrombosis|2018Cited by 821
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 VersionTamio Teramoto, Koutaro Yokote, Junichi Sasaki et al.|Journal of Atherosclerosis and Thrombosis|2013Cited by 469
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaúl D. Santos, Shizuya Yamashita, Steve E. Humphries et al.|The Lancet Diabetes & Endocrinology|2016Cited by 418
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017Mariko Harada‐Shiba, Hidenori Arai, Yasushi Ishigaki et al.|Journal of Atherosclerosis and Thrombosis|2018Cited by 226
Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.Shizuya Yamashita, David Y. Hui|Journal of Clinical Investigation|1990Cited by 184